Macro Group Pharmaceutical SAE EGX:MCRO:
MACRO GROUP PHARMACEUTICAL FY CONSOL PROFIT ATTRIBUTABLE EGP 115.7 MILLION
MACRO GROUP PHARMACEUTICAL FY CONSOL NET SALES EGP 894.5 MILLION
Macro Group Pharmaceutical FY Consol Profit EGP 115.7 Mln
Earlier from Macro Group Pharmaceutical S.a.e
- MACRO Group Pharmaceutical 9-Month Consol Loss EGP 66.1 Million
- Macro Group Pharmaceutical Shareholders Approve Authorized Capital Increase To EGP 3 Bln